Insiders Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

End-of-day quote Taiwan S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
42.35 ^TWD	+4.05%		+9.43%	-34.95%

05-28	Tanvex BioPharma, Inc.(TWSE:6541) dropped from S&P Global BMI Index	CI
05-13	Tanvex BioPharma, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tanvex BioPharma, Inc. Announces the Appointment of James Williamson as Accounting Officer	02-06	CI
Tanvex BioPharma, Inc. Announces the Appointment of Chen, Lin-Cheng as CEO	02-06	CI
Tanvex BioPharma, Inc. Announces the Resignation of Ken Huang as Accounting Officer	01-05	CI
Tanvex BioPharma, Inc. Announces Change of Chairman	12-29	CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen Chairperson and Director, Effective December 29, 2023	12-21	CI
Tanvex BioPharma, Inc. Announces Change of Corporate Governance Officer	12-21	CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as CEO, Effective December 29, 2023	12-21	CI
Tanvex BioPharma, Inc. Announces Resignation of Yun Yen as Chairman/President, Effective December 29, 2023	12-21	CI
Tanvex BioPharma, Inc. Announces the Resignation of Stacey Tsai as Acting Spokesperson and Corporate Governance Officer	11-30	CI
Tanvex BioPharma, Inc. Appoints Wen Chung Yeh as Chief Financial Officer	11-13	CI
Tanvex BioPharma, Inc. Announces Management Changes	11-01	CI
Tanvex BioPharma, Inc. Appoints Peter K.H. Lin as Agent in Charge of Accounting Officer	03/03/23	CI
Tanvex BioPharma, Inc. Announces Position Adjustment of Accounting Officer from Peter K.H. Lin to Ken Huang	20/02/23	CI
Tanvex Biopharma, Inc. Announces Position Adjustment of Acting Spokesperson and Corporate Governance Officer from Jerry Yu to Stacey Tsai	20/02/23	CI
Tanvex BioPharma, Inc. Announces the Appointment of Jang-Yang Chang as Member of Remuneration Committee	15/07/22	CI
Tanvex BioPharma, Inc. Appoints Jang-Yang Chang as Independent Director	17/06/22	CI
Tanvex BioPharma, Inc. Announces the Appointment of K. H. Lin as CFO and Accounting Officer, Effective from February 18, 2022	18/02/22	CI
Tanvex BioPharma, Inc. Announces the Appointment of Yun Yen as Chief Executive Officer	18/02/22	CI
Tanvex BioPharma, Inc. Announces Resignation of Lanbo Chen as Independent Director	06/01/22	CI
Tanvex Biopharma, Inc. Announces Resignation of James Williamson as Corporate Controller	04/01/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Tanvex BioPharma, Inc.

Equities

6541

KYG8676P1037

Insiders

Filters